Studies on Strategies for Enhancing Vaccine Immunogenicity

Dear Colleagues,

The immunogenicity of a vaccine is determined by the characteristics of the specific antigens and the specific vaccine formulation used, as well as the characteristics of the immune response and other genetic factors of the target host. Therefore, variables such as antigen concentration and presentation, adjuvant requirements, delivery strategy, vaccine stability and handling, and manufacturing/distribution characteristics can affect population and individual host responses (and therefore, effectiveness).

The current COVID-19 pandemic has once again proved the importance of vaccines, so it is necessary to understand the determinants of the immune response to vaccines and understand their role in vaccine antigenicity and effectiveness.

We hope to encourage the introduction of recent developments in this Special Issue, focusing on understanding the molecular mechanisms that trigger protective immune responses from immunnization, and evaluating the contribution of adjuvants and immunomodulatory molecules to vaccine immunogenicity and induction of long lasting immunological memmory.

This Special Issue focuses on the latest research studies that define innovative strategies for enhancing vaccine immunogenicity. Submissions of original articles, systematic reviews, short communications, and other types of articles on related topics are welcomed. All manuscripts will follow standard journal peer-review practices.

We look forward to receiving your contributions to the Special Issue.

Prof. Dr. David Scott McVey
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.